The companies agreed to licence ConsultorioMOVIL free of charge for professionals nation wide
Argentine Diabetologists and Endocrinologists can now access and use ConsultorioMOVIL free of charge thanks to a sponsoring deal that Novo Nordisk and ConsultorioMOVIL plan to execute during 2016.
ConsultorioMOVIL offers a great communication and educational tool for both doctors and patients with chronical treatments.
Argentine diabetic population keeps growing at a strong pace, and every public and private health player is investing time and resources on patients’ education — aiming early diagnostics and improved adherence to treatments.
For more information see www.novonordisk.com.ar